Cautious optimism the key with Covid-19 vaccine breakthrough: The Yorkshire Post says

Prime Minister Boris Johnson during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: Tolga Akmen/PA WirePrime Minister Boris Johnson during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: Tolga Akmen/PA Wire
Prime Minister Boris Johnson during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: Tolga Akmen/PA Wire
As Pfizer announced its fledging vaccine can prevent more than 90 per cent of people from getting Covid-19, chairman Dr Albert Bourla memorably stated; “Today is a great day for science and humanity”.

The virus, which was not known to be in existence this time last year, has been involved in more than one million deaths across the world and has caused huge economic devastation.

As England embarks on the early stages of its second national lockdown, this news appears to offer some light at the end of the tunnel that everyone has been desperate for – something reflected in the markets as tens of billions was added to the value of shares on the FTSE 100 following the announcement.

Hide Ad
Hide Ad

But there are of course, some very important caveats – the study is still ongoing and safety and efficacy data continues to be collected, meaning the vaunted 90 per cent figure could well change. There are also question marks over how long immunity would last.

Deputy Chief Medical officer Jonathan Van-Tam during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: PA Video/PA WireDeputy Chief Medical officer Jonathan Van-Tam during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: PA Video/PA Wire
Deputy Chief Medical officer Jonathan Van-Tam during a media briefing in Downing Street, London, on coronavirus (COVID-19). Picture: PA Video/PA Wire

Equally, the news has been delivered by a Pfizer press release rather than a peer-reviewed medical journal and any global rollout will come with considerable logistical challenges and take many months to carry out. However, to date no serious safety concerns have been observed and the reported efficacy rate of the vaccine would put it on a par with highly effective childhood vaccines for diseases like measles.

There are no guarantees at all but as one of 11 potential vaccines in late-stage trials, there are growing signs that the coronavirus pandemic that has caused so much misery in so many different ways across the world can be overcome. As Boris Johnson memorably put it in a Downing Street press conference tonight, the sound of the “bugle of the scientific cavalry coming over the brow of the hill... is louder but still some way off”.

Support The Yorkshire Post and become a subscriber today. Your subscription will help us to continue to bring quality news to the people of Yorkshire. In return, you’ll see fewer ads on site, get free access to our app and receive exclusive members-only offers. Click here to subscribe.

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.

News you can trust since 1754
Follow us
©National World Publishing Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice